Insulet (PODD) Accounts Payables (2010 - 2026)
Insulet (PODD) posted Accounts Payables of $149.8 million for Q1 2026, up 99.73% on a QoQ basis from $75.0 million in Q4 2025, and up 160.07% year-over-year from $57.6 million in Q1 2025.
Insulet (PODD) Accounts Payables (2010 - 2026) Analysis & Trends
Insulet's Accounts Payables history runs 17 years deep, the most recent figure standing at $149.8 million for Q1 2026.
- Quarterly Accounts Payables rose 160.07% year-over-year to $149.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $149.8 million (up 160.07% YoY) and the FY2025 annual result came in at $75.0 million, up 278.79% from the prior year.
- Accounts Payables was $149.8 million for Q1 2026 at Insulet, up from $75.0 million in the prior quarter.
- Across five years, Accounts Payables topped out at $149.8 million in Q1 2026 and bottomed at $19.2 million in Q4 2023.
- A 5-year average of $66.6 million and a median of $62.1 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables sank 48.2% — and 2025, when it surged 278.79%.
- Insulet's Accounts Payables stood at $30.8 million in 2022, then slumped by 37.66% to $19.2 million in 2023, then grew by 3.12% to $19.8 million in 2024, then jumped by 278.79% to $75.0 million in 2025, then jumped by 99.73% to $149.8 million in 2026.
- Business Quant data shows PODD's Accounts Payables at $149.8 million in Q1 2026, $75.0 million in Q4 2025, and $48.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 3.41 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 1.18 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 2.33 Bn |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | 149.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.80 Mn |
| Dec 31, 2025 | 75.00 Mn |
| Sep 30, 2025 | 48.20 Mn |
| Jun 30, 2025 | 96.10 Mn |
| Mar 31, 2025 | 57.60 Mn |
| Dec 31, 2024 | 19.80 Mn |
| Sep 30, 2024 | 40.30 Mn |
| Jun 30, 2024 | 76.80 Mn |
| Mar 31, 2024 | 75.90 Mn |
| Dec 31, 2023 | 19.20 Mn |
| Sep 30, 2023 | 77.80 Mn |
| Jun 30, 2023 | 107.50 Mn |
| Mar 31, 2023 | 85.90 Mn |
| Dec 31, 2022 | 30.80 Mn |
| Sep 30, 2022 | 62.10 Mn |
| Jun 30, 2022 | 57.20 Mn |
| Mar 31, 2022 | 52.20 Mn |
| Dec 31, 2021 | 37.70 Mn |
| Sep 30, 2021 | 58.00 Mn |
| Jun 30, 2021 | 49.30 Mn |